Aegis Capital Starts BiondVax Pharmaceuticals (BVXV) at Buy
Tweet
Share
E-mailGet Alerts BVXV Hot Sheet
Price: $1.36 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Aegis Capital earlier initiated coverage on BiondVax Pharmaceuticals (NASDAQ: BVXV) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on BiondVax Pharmaceuticals click here. For more ratings news on BiondVax Pharmaceuticals click here.
Shares of BiondVax Pharmaceuticals closed at $4.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Leerink Starts Freenome Inc. (FRNM) at Outperform
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
